ArticleEuropean journal of cancer (Oxford, England : 1990)2020

A polymorphism within the R-spondin 2 gene predicts outcome in metastatic colorectal cancer patients treated with FOLFIRI/bevacizumab: data from FIRE-3 and TRIBE trials.

Martin D Berger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.